Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03946800
Title A Study of MEDI1191 Alone and in Combination With Durvalumab in Subjects With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC

Advanced Solid Tumor



Durvalumab + MEDI1191

Age Groups: senior | adult
Covered Countries USA | FRA | ESP

No variant requirements are available.